Ethical Considerations in CAR T-cell Therapy

Join us for this interview with Dr Río-Machín from Autonomous University of Madrid in Spain as she discusses her research on rare subtypes of acute myeloid leukemia (AML), which she conducted thanks to the EHA Junior Research Grant. Her discovery of transcriptional activator of k ...  Show more

Join us for this discussion between Prof Argiris Symeonidis from University of Patras in Greece and Prof Sam Salek from University of Hertfordshire in UK who focus on the role of the hematologist in the diagnosis and management of patients with Gaucher disease. Prof Symeonidis an ...  Show more

In this conversation, host Monique Koven has invited Dr Ingrid Clayton back to answer your questions. They explore the concept of fawning as a relational trauma response, discussing its implications on identity, relationships, and personal growth. They delve into the complexities ...  Show more

New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the treatment algorithm, and how do you administer them? This installment of the 2025 NMIBC Creator Weekend™ series features host Dr. Bogdana Schmidt, assistant professor ...  Show more

When I first had Mark Dixon on the podcast, way back in Session 14, we poked some fun at the notion that principles of Acceptance and Commitment Therapy, on the surface, didn't meet many of the 7 dimensions of Applied Behavior Analysis. Well, in Session 50, I'm joined by Dr. Jona ...  Show more

This episode, hosts Sophie Neale and Dr. Tanner Schrank discuss putting that medical school knowledge into practice, focusing on the importance of communication, empathy and strong interpersonal skills when working directly with patients. Exploring this topic from both a physicia ...  Show more